CoChat

Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial*

Honeycutt, Travis C. B., El Khashab, Mohamed, Wardrop, Richard M., McNeal-Trice, Kenya, Honeycutt, Andrea L. B., Christy, Claudia G., Mistry, Kshitij, Harris, Bradford D., Meliones, Jon N., Kocis, Keith C. · 2007 · Pediatric Critical Care Medicine
Cited by 133

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Objective: To evaluate the efficacy of probiotics in reducing the rates of nosocomial infection in pediatric intensive care. Design: Randomized, double-blind, placebo-controlled trial. Setting: A 16-bed pediatric intensive care unit in a university-affiliated children’s hospital. Patients: Sixty-one pediatric patients were enrolled from April 2004 until December 2004. Screening of all patients admitted occurred on a daily basis. Patients were excluded if they had the following: evidence/suspicion of intestinal perforation, evidence/suspicion of mechanical gastrointestinal obstruction, absolute neutrophil count ≤0.5 × 109 cells/L, judgment by the attending physician that unable to tolerate the enteral volume necessary for administration, use of a probiotic preparation at any time in the week before study entry, participation in another clinical trial, lack of parental presence, or lack of parental consent. Interventions: Patients were randomized to receive either one capsule of Lactobacillus rhamnosus strain GG (Culturelle, ConAgra Foods, Omaha, NE) or placebo capsule of insulin once a day until discharge from the hospital. Results: Sixty-one patients were randomized: 31 in the treatment group and 30 on the placebo group. Three patients in the control group developed four infections. Six patients in the treatment group developed 11 infections. The relative risk of developing infection in the treatment group was 1.94 (confidence interval [CI], 0.53 to 7.04; p = .31). The mean number of infections in the treatment and control groups was 1.83 and 1.33, respectively, with a difference of 0.5 (p = .52). No serious adverse effects in the study population were noted. However, due to recent safety concerns regarding the administration of L. rhamnosus strain GG and a lack of benefit in this interim analysis, the study was terminated by the study investigators. Conclusions: The results of this preliminary investigation were unexpected but important in view of the increased use of probiotic preparations in medically fragile pediatric patients. In this randomized, placebo-controlled trial, L. rhamnosus strain GG was not shown to be effective in reducing the incidence of nosocomial infections. In fact, a statistically nonsignificant trend toward an increase in infection was seen (four vs. 11). Further studies with a larger patient population are needed to establish both safety and efficacy of probiotics in pediatric critical care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.pcc.0000282176.41134.e6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 133

Metadata

Authors
Honeycutt, T. C. B., El Khashab, M., Wardrop, R. M., McNeal-Trice, K., Honeycutt, A. L. B., Christy, C. G., Mistry, K., Harris, B. D., Meliones, J. N., & Kocis, K. C.
Venue
Pediatric Critical Care Medicine
Published
2007-09
Volume
8
Issue
5
Pages
452-458
ISSN
1529-7535 (ISSN-L)
OpenAlex
W2038731212
Cited by
133
References
5
FWCI
16.98
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial*. https://app.cochat.ai/papers/10.1097/01.pcc.0000282176.41134.e6
The paper
Honeycutt, T. C. B., El Khashab, M., Wardrop, R. M., McNeal-Trice, K., Honeycutt, A. L. B., Christy, C. G., Mistry, K., Harris, B. D., Meliones, J. N., & Kocis, K. C. (2007). Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial*. Pediatric Critical Care Medicine. https://doi.org/10.1097/01.pcc.0000282176.41134.e6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.